<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="371397">
  <stage>Registered</stage>
  <submitdate>29/08/2016</submitdate>
  <approvaldate>6/09/2016</approvaldate>
  <actrnumber>ACTRN12616001237471</actrnumber>
  <trial_identification>
    <studytitle>Trial of the Patney open airway device for snoring and mild obstructive sleep apnoea</studytitle>
    <scientifictitle>Validation trial of the Patney open airway device in snorers and mild obstructive sleep apnoea - subjective report of comfort and outcomes</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Obstructive sleep apnoea</healthcondition>
    <healthcondition>snoring</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Sleep apnoea</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The Patney OAD is a pillow device designed to open the airway and reduce snoring / obstructive sleep apnoea. It will be used each night during a period of sleep over one week at subjects home. Detailed instructions will be provided by WellSleep staff trained in its use. Subjects and their partners will provide subjective feedback on their experience.</interventions>
    <comparator>Control is usual practice with regards to current pillow</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Sleep quality from the use of likert scales (1-10). The questionnaire is an in-house questionnaire designed specifially for this study.</outcome>
      <timepoint>After one week of device use</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Average total sleep time from sleep diary - in house questionnaire</outcome>
      <timepoint>Each night over the one week trial with the product</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Snoring level - sujectively measured by partner sleeping in same bed.  This will be on a likert scale and compare to usual snoring.</outcome>
      <timepoint>After one week of device use</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Comfort of device. Determined by in house questionnaire designed for this study.</outcome>
      <timepoint>after one week of device use</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Objectively determined snoring (snoring plus apnoea Index &lt; 5 /hr) or mild OSA (Apnoea index 5-15/hr)
Not using any other treatment for snoring/mild OSA
Partner sleeping in same bed</inclusivecriteria>
    <inclusiveminage>25</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Musculoskeletal issues
Severe OSA
Separate sleeping arrangements
Use of other treatment for snoring / mild OSA</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>3/10/2016</anticipatedstartdate>
    <actualstartdate>13/10/2016</actualstartdate>
    <anticipatedenddate />
    <actualenddate>10/05/2017</actualenddate>
    <samplesize>20</samplesize>
    <actualsamplesize>20</actualsamplesize>
    <currentsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>10/05/2017</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Wellington</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Otago University Wellington</primarysponsorname>
    <primarysponsoraddress>PO Box 7343
Wellington 6242</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Patney Ltd</fundingname>
      <fundingaddress>c/- BDO Waikati
1026 Victoria St
Hamilton 3200
New Zealand</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Treatment devices for snoring and mild OSA available over the counter have not been well validated. This study aims to determine whether a new product - the Patney Open Airway Device is suitable for people who snore and have mild OSA in terms of treating these issues. Patients will initially trial the device for one week and provide feedback on the comfort of the device plus the effect on symptoms.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Health and Disability Ethics Committee</ethicname>
      <ethicaddress>MOH
PO Box 5013
Wellington</ethicaddress>
      <ethicapprovaldate>18/08/2016</ethicapprovaldate>
      <hrec>16/CEN/85</hrec>
      <ethicsubmitdate>1/07/2016</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Angela Campbell</name>
      <address>C/- Dept Medicine
University of Otago Wellington
PO Box 7343
Wellington</address>
      <phone>+64 4 9208819</phone>
      <fax />
      <email>angela.campbell@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Angela Campbell</name>
      <address>C/- Dept Medicine
University of Otago Wellington
PO Box 7343
Wellington</address>
      <phone>+64 4 9208819</phone>
      <fax />
      <email>angela.campbell@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Angela Campbell</name>
      <address>C/- Dept Medicine
University of Otago Wellington
PO Box 7343
Wellington</address>
      <phone>+64 4 9208819</phone>
      <fax />
      <email>angela.campbell@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>